Title: FDA Grants Therapy Designation for Ocrelizumab in Primary Progressive MS
Description: FDA grants breakthrough therapy designation for the investigational medicine Ocrelizumab (OCREVUS) for treatment of primary progressive multiple sclerosis (PPMS).
URL: https://www.disabled-world.com/medical/clinical-trials/ocrelizumab.php
Confused by Google's Search Result Shambles? View more Disabled World content by adding us as a source for relevant searches. Click the button above, find Disabled World on the Google page that opens, and check the box on the right.